Jefferies Group’s Impax Laboratories, Inc. IPXL Stock Holding History

Jefferies Group’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-14,881	Closed	-$248K	–	2989
2017 Q4	$248K	Buy	+14,881	New	+$273K	﹤0.01%	2104
2017 Q2	–	Sell	-2,733	Closed	-$35K	–	2790
2017 Q1	$35K	Sell	2,733 -54,160	-95%	-$654K	﹤0.01%	2219
2016 Q4	$754K	Buy	56,893 +12,803	+29%	+$219K	﹤0.01%	1421
2016 Q3	$1.04M	Buy	+44,090	New	+$1.19M	0.01%	1262
2016 Q2	–	Sell	-10,292	Closed	-$330K	–	2612
2016 Q1	$330K	Buy	10,292 +1,792	+21%	+$63K	﹤0.01%	1631
2015 Q4	$363K	Sell	8,500 -32,262	-79%	-$1.29M	﹤0.01%	1703
2015 Q3	$1.44M	Buy	40,762 +40,662	+40,662%	+$1.83M	0.01%	1049
2015 Q2	$5K	Buy	+100	New	+$4.75K	﹤0.01%	3009
2014 Q4	–	Sell	-12,884	Closed	-$305K	–	2527
2014 Q3	$305K	Buy	+12,884	New	+$330K	﹤0.01%	1599
2014 Q2	–	Sell	-313	Closed	-$8K	–	2527
2014 Q1	$8K	Buy	+313	New	+$7.82K	﹤0.01%	1953
2013 Q3	–	Sell	-25,873	Closed	-$515K	–	2328
2013 Q2	$515K	Buy	+25,873	New	+$459K	0.01%	1053

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jefferies Group's IPXL Position: Q1 2018 in Review

Jefferies Group sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 14,881 shares — an estimated $248K sold.

Jefferies Group first reported a position in IPXL in Q2 2013 and held it in 11 quarters. The position peaked at $1.44M in Q3 2015. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.

Jefferies Group reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
Jefferies Group sold 14,881 Impax Laboratories, Inc. shares in Q1 2018, an estimated $248K.
Jefferies Group first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 11 quarters.
Jefferies Group's Impax Laboratories, Inc. position peaked at $1.44M in Q3 2015.
188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.

Based on Jefferies Group's 13F filing for Q1 2018, filed 15 May 2018.